n/a (PBE)

NYSEArca: PBE · Echtzeitkurs · USD

93.47

-1.81 (-1.90%)

Zum Schluss: Aug 14, 2026, 1:46 PM

-1.90% (1D)

Keine Daten verfügbar

Geld	97.87
Marktkapitalisierung	n/a
Umsatz (TTM)	n/a
Nettogewinn (TTM)	n/a
Beta	n/a
EPS (ttm)	n/a
KGV (TTM)	25.15
Forward-KGV	n/a
KBV (TTM)	n/a
KUV (TTM)	n/a
Earnings Date	n/a

Brief	98.09
Volumen	2,871
Ø Vol. (20D)	22,979
Eröffnung	96.32
Vortagesschluss	95.28
Tagesspanne	96.88 - 97.98
52-Wk Range	67.41 - 97.98
Analyst	n/a
Kursziel	n/a
Dividenden	n/a
Ex-Dividenden-Datum	n/a

Über PBE

A detailed description of the company is not yet available....

[Mehr lesen]

Branche n/a

Sektor n/a

IPO Datum n/a

Mitarbeiter n/a

Börse n/a

Tickersymbol PBE

Vollständiges Unternehmensprofil

Nachrichten

vor 6 Tagen · Zacks

Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?

Smart Beta ETF report for PBE

vor 1 Woche · Zacks

Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

vor 3 Wochen · 24/7 Wall St.

ETF Showdown: XBI vs PBE, Which Biotech Fund Wins?

XBI and PBE both bet on biotech, but their structures pull in opposite directions when markets turn volatile. Knowing which one fits your risk appetite could mean the difference between riding a catal...

vor 9 Monaten · Zacks

Inside the Recent Strength in Biotech ETFs

Biotech strength is back, with IBB, PBE, FBT, CANC and HELX climbing as cheaper valuations, rate-cut hopes, FDA approvals and strong deal activity fuel biotech gains.

vor 9 Monaten · Zacks

2 ETFs to Watch for Outsized Volume on Biotechnology Stocks

Biotech ETFs PBE and FBT saw trading volumes soar to over four times their averages, signaling rising interest amid a down day for major indexes.

n/a (PBE)

Über PBE

Gewinnüberraschung

Why Price Moved